Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Jason Helfstein Downgrades FIGS Rating from Outperform to Perform

Elaine Mendonca by Elaine Mendonca
March 8, 2024
in Breaking News
0
Finances
0
SHARES
9
VIEWS
Share on FacebookShare on Twitter

On March 8, 2024, Oppenheimer analyst Jason Helfstein made a significant adjustment to his rating on FIGS (NYSE: FIGS), downgrading it from Outperform to Perform. This shift in perspective signals a change in Helfstein’s assessment of the stock’s potential performance.

Helfstein, a respected figure in stock analysis at Oppenheimer, has a history of evaluating a wide range of sectors and issuing ratings on numerous stocks. His decision to downgrade FIGS falls in line with his continuous evaluations of various companies and industries, highlighting the ever-evolving nature of stock analysis and market dynamics.

FIGS Stock Price Decline: Analysis and Forecast for March 8, 2024

On March 8, 2024, FIGS stock experienced a slight decline in its price momentum. According to data from CNN Money, FIGS is currently trading near the bottom of its 52-week range and below its 200-day simple moving average. This indicates that the stock may be facing some downward pressure in the short term.

The price of FIGS shares decreased by $0.02 since the market last closed, representing a 0.37% drop. The stock closed at $5.36 on the previous trading day. However, in pre-market trading on March 8, the stock dropped a further $0.17, signaling a potential continuation of the downward trend.

Investors and analysts will be closely monitoring FIGS stock performance throughout the day to see if the downward momentum continues or if the stock is able to rebound. Factors such as market conditions, company news, and overall industry trends could all impact FIGS stock performance in the short term.

FIGS Inc. Reports Strong Financial Performance with Revenue and Income Growth

FIGS Inc. (FIGS) had a mixed performance on March 8, 2024, as the stock price fluctuated throughout the day. According to data from CNN Money, FIGS reported total revenue of $545.65 million for the past year, representing a 7.87% increase compared to the previous year. Net income for FIGS stood at $22.64 million for the past year, reflecting a 6.85% increase compared to the previous year. Earnings per share (EPS) for FIGS were reported at $0.12 for the past year, showing a 9.82% increase compared to the previous year. Overall, FIGS demonstrated solid financial performance over the past year, with increases in total revenue, net income, and earnings per share. Investors will be keeping a close eye on FIGS stock as they assess the company’s future growth prospects and potential for further gains in the market.

Tags: FIGS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
DrugRetailers Trading online

Analysts Raise Price Targets for Burlington Stores After Strong Q4 Results

Neptune Wellness Solutions Announces Major Leadership Changes

Technology Artificial intelligence Market Capitalization

Analysts Divided on Marvell Technologys Potential

Recommended

Biotechnology Market Capitalization

Analyst Upgrades Price Target for Nuvation Bio to 5

2 years ago
CryoLife Stock

Medical Device Specialist Artivion Maintains Strong Analyst Backing

3 months ago
Walgreens Boots Alliance Stock

Walgreens Concludes Public Trading Era Following Landmark Acquisition

3 months ago
MA stock news

Analysis of Short Interest and Financial Performance of US Bancorp

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Procter & Gamble Shares Approach a Critical Juncture

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

Palantir Shares: A Wall Street Divide and a Bold New Price Target

Trending

Eli Lilly Stock
AI & Quantum Computing

Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances

by Felix Baarz
January 11, 2026
0

Eli Lilly and Company has opened 2026 with a clear strategic push to diversify and strengthen its...

Alibaba Stock

Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs

January 11, 2026
Vulcan Energy Stock

Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

January 11, 2026
Viking Therapeutics Stock

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

January 11, 2026
Astera Labs Stock

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Eli Lilly Charts Aggressive Growth Path with Strategic Acquisitions and Pipeline Advances
  • Alibaba’s Strategic Crossroads: Balancing AI Ambition Against Rising Costs
  • Vulcan Energy Shares Navigate Investor Reshuffle Amid Major Project Funding

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com